MyFID is a programmable dosing device for tablets. By combining the possibilities of a modern technology and tablets with a smaller amount of active ingredients, a fine-tuned dosing can be achieved. By choosing a number of tablets a specific, individualized dose can be arrived.
MyFID is pre-programmed to deliver a certain amount of medicine at a certain time. The physician decides which dose a patient should use and when it should be taken. However in order for the device not to rule the user’s life, care has been taken to ensure that the user choose which functions of the device that should be active.
MyFID has unique registration capabilities. It registers the amount and time a dose is delivered. MyFID will ask and record reasons why a dose is taken. It also records disease symptoms using easy to use scales that allows for the patient and the doctor to follow treatment effects, to get a continuous picture of how the disease evolves and fluctuates with time.
All information recorded is available for both the user and the physician, and can be retrieved using an inbuilt standardized treatment report. MyFID therefore gives the physician and the patient a more precise and correct background for further treatment decisions.
Sensidose AB is a pharmaceutical company that has developed a system for individualized dosing of pharmaceutical tablets, allowing for a fine tuned and patient centered drug therapy.
191 38 Sollentuna, Sverige